Lung Cancer in the Brazilian Health System: Screening, Drug Approvals, Barriers to Care, and Success Stories
By Ricardo Sales dos Santos, MD, PhD, and Juliana Franceschini, PhD Posted: June 24, 2020 Dr. Juliana Franceschini Dr. Ricardo Sales dos Santos […] Read more
Karen L. Reckamp, MD, MS
Posted: June 24, 2020 In addition to her roles of Associate Director for Clinical Research at Cedars-Sinai Cancer and Medical Oncology Director of Women’s Guild Lung Institute in the Department […] Read more
Single-Agent Pembrolizumab Active Against STK11- and KEAP1- Mutated NSCLC According to KEYNOTE-042 Analysis
By Kara Nyberg, PhD Posted: June 24, 2020 Genomic alterations in STK11 and KEAP1 represent two of the most common and potent contributors to a cold tumor immune microenvironment in […] Read more
Tobacco Use Assessment and Cessation Support: More Important Now Than Ever
Dr. Matthew SteligaIt is well known that ongoing tobacco use is associated with poorer survival in patients with cancer, and the IASLC has emphasized this message.1 The Declaration from IASLC: Tobacco Cessation […] Read more
Multidisciplinary Tumor Board: A Single Institution’s Perspective
By Ari Rosenberg, MD Posted: June 24, 2020 As 7:00 AM approaches, the ninth-floor conference room slowly fills as team members file in and find their seats. The senior […] Read more
David LeDuc
Posted: June 24, 2020 David LeDuc has been named Associate Director, Oncology Patient Affairs at Astra-Zeneca. In this role, Mr. LeDuc will be responsible for building and strengthening relationships with […] Read more
Gideon Blumenthal, MD
Posted: June 24, 2020 Gideon Blumenthal, MD, has transitioned from Deputy Director of the Oncology Center of Excellence (OCE) at the U.S. Food and Drug Administration (FDA) to Vice President […] Read more
Prior Pneumonitis as a Risk Factor for Treatment-Associated Pneumonitis With Immune Checkpoint Inhibitor Therapy
By Kara Nyberg, PhD Posted: June 24, 2020 Pneumonitis is a well-known complication associated with immune checkpoint inhibitors (ICI). A collaborative effort between the U.S. Food and Drug Administration (FDA) […] Read more
Shirish Gadgeel, MD
Posted: June 24, 2020 Shirish Gadgeel, MD, is now the Chief of Division of Hematology and Oncology and Associate Director of Patient Experience and Clinical Care at Henry Ford Cancer […] Read more
Multidisciplinary Tumor Boards: Approaches Across Different Institutions
Posted: June 24, 2020 In an effort to provide its audience with information about best practices for multidisciplinary communication, ILCN will be highlighting the approaches of different international institutions. From […] Read more